Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas

Journal of the National Cancer Institute

Volumn 85, Issue 5, 1993, Pages 377-384

  Suzuki, Takashi ^a   Bogenmann, Emil ^a   Shimada, Hiroyuki ^a   Stram, Daniel ^a,b   Seeger, Robert C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Children's Cancer Study Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR;

ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; GENE AMPLIFICATION; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; NEUROBLASTOMA; ONCOGENE C MYB; PRIORITY JOURNAL; RECEPTOR AFFINITY; TUMOR GROWTH;

HUMAN; NEOPLASM STAGING; NEUROBLASTOMA; PROGNOSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENES; RECEPTOR, TRKA; RECEPTORS, NERVE GROWTH FACTOR; RETROSPECTIVE STUDIES; RNA, MESSENGER; RNA, NEOPLASM; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL ANALYSIS;

EID: 0027456537     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/85.5.377     Document Type: Article

References (42)

1. Bothwell M: Keeping track of neuro- trophin receptors. Cell 65:915-918, 1992
2. Levi-Montalcini R: The nerve growth factor 35 years later. Science 237:11541162, 1987
3. Martin-Zanca D, Oskam R, Mitra G, et al: Molecular and biochemical characterization of the human trie proto-oncogene. Mol Cell Biol 9:24-33, 1989
4. Kaplan DR, Hempstead BL, Martin- Zanca D, et al: The trk proto-oncogene product: A signal transducing receptor for nerve growth factor. Science 252:554-558, 1991
5. Klein R, Jino SQ, Nanduri V, et al: The trk proto-oncogene encodes a receptor for nerve growth factor. Cell 65:189-197, 1991
6. Barbacid M, Lamballe F, Pulido D, et al: The trk family of tyrosine protein kinase receptors. Biochim Biophys Acta 1072:115-127, 1991
7. Johnson D, Lanahan A, Buck CR, et al: Expression and structure of the human NGF receptor. Cell 47:545-554, 1986
8. Radeke MJ, Misko TP, Hsu C: Gene transfer and molecular cloning of the rat nerve growth factor. Nature 319:593-597, 1987
9. Kaplan DR, Martin-Zanca D, Parada LF: Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF. Nature 350:158— 160, 1991
10. Loeb DM, Maraoos J, Martin-Zanca D, et al: The trk proto-oncogene rescues NGF responsiveness in mutant NGF-nonre- sponsive PC12 cell lines. Cell 66:961-966, 1991
11. Berg MM, Sternberg DW, Hempstead BL, et al: The low-affinity p75 nerve growth factor (NGF) receptor mediates NGF-induced tyrosine phosphorylation. Proc Natl Acad Sci U S A 88:7106-7110, 1991
12. Hempstead BL, Martin-Zanca D, Kaplan DR, et al: High-affinity NGF binding requires coexpression of the trk protooncogene and the low-affinity NGF receptor. Nature 350:678-683, 1991
13. Cordon-Cardo C, Tapley P, Jino SQ, et al: The trk tyrosine protein kinase mediates the mitogenic properties of nerve growth factor and neurotrophin-3. Cell 66:173-183, 1991
14. Seeger RC, Reynolds CP: Neuroblastoma. In Cancer Medicine (Holland JF, Frei E 111, Bast RC Jr, et al, eds). Philadelphia: Lea and Febiger. In press
15. Shimada H, Chatten J, Newton WA Jr, et al: Histopathologic prognostic factors in neuroblastic tumors: Definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. JNCI 73:405-416, 1984
16. Brodeur GM, Seeger RC, Schwab M, et al: Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224:11211124, 1984
17. Seeger RC, Brodeur GM, Sather H, et al: Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313:1 Hill 16, 1985
18. Reynolds CP, Frenkel EP, Smith RG: Growth characteristics of neuroblastoma in vitro correlate with patient survival. Trans Assoc Am Physicians 93:203-211, 1980
19. Reynolds CP, Tomayko MM, Donner L, et al: Biological classification of cell lines derived from human extra-cranial neural tumors. Prog Clin Biol Res 271:291-306, 1988
20. Azar C, Scavarda NJ, Reynolds CP, et al: Multiple defects of the nerve growth factor receptor in human neuroblastomas. Cell Growth Diff 1:421-28, 1990
21. Chen J, Chattopadhyay B, Venka- takrishnan G, et al: Nerve growth factor-induced differentiation of human neuroblastoma and neuroepithelioma cell lines. Cell Growth Differ 1:79-85, 1990
22. Reynolds CP, Perez-Polo JR: Nerve growth factor induces neurite outgrowth in a clone derived from an NGF-insensitive human neuroblastoma cell line. Int J Dev Neurosci 7:125-132, 1989
23. Baker DL, Reddy UR, Pleasure D, et al: Analysis of nerve growth factor receptor expression in human neuroblastoma and neuroepithelioma cell lines. Cancer Res 49:4142-4146, 1989
24. Christiansen H, Christiansen NM, Wagner F, et al: Neuroblastoma: Inverse relationship between expression of N-myc and NGF-r. Oncogene 5:437-440, 1990
25. Baker DL, Molenaar WM, Trojanowski JQ, et al: Nerve growth factor receptor expression in peripheral and central neuroectodermal tumors, other pediatric brain tumors, and during development of the adrenal gland. Am J Pathol 139:115-122, 1991
26. Nakaoawara A, Arima M, Azar CG, et al: Inverse relationship between trk expression and N-myc amplification in human neuroblastomas. Cancer Res 52:1364-1368, 1992
27. Suzuki T, Booenmann E, Stram D, et al: Neuroblastomas lacking high affinity nerve growth factor (NGF) receptors (gpl40proto-trk) rapidly progress. Proc Amer Assoc Cancer Res 32:210, 1992
28. Evans AE, D’Angio GJ, Randolph J: A proposed staging for children with neuroblastoma. Children’s Cancer Study Group A. Cancer 27:374-378, 1971
29. Martin-Zanca D, Hughes SH, Barbacid M: A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences. Nature 319:743-748, 1986
30. Schwab M, Alitalo K, Klempnauer KH, et al: Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 305:245248, 1983
31. Ponte P, Gunning P, Blau H, et al: Human actin genes are single copy for alpha-skeletal and alpha-cardiac actin but multicopy for beta- and gamma-cytoskeletal genes: 3' untranslated regions are isotype specific but are conserved in evolution. Mol Cell Biol 3:1783-1791, 1983
32. Sambrook J, Fritisch EF, Maniatis T: Molecular Cloning. A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989 Chromczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1962
33. Armitage P: Statistical Methods in Medical Research. Oxford: Blackwell Publ, 1992 Cox DR: Regression models and life tables. J Royal Stat Soc-B 34:187-220, 1972
34. Peto R, Pike MC, Armitage P: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35:1-39, 1977
35. Nebreda AR, Martin-Zanca D, Kaplan DR, et al: Induction by NGF of meiotic maturation of Xenopus oocytes expressing the trk proto-oncogene product. Science 252:558-561, 1991
36. Itoh N, Yonehara S, Ishii A, et al: The polypeptide encoded by the cDNA for human cell antigen Fas can mediate apop- tosis. Cell 66:233-243, 1991
37. Mallett S, Barclay AN: A new superfamily of cell surface proteins related to the nerve growth factor receptor. Immunol Today 12:220-223, 1991
38. Durkop H, Latza U, Hummel M, et al: Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin’s disease. Cell 68:421-127, 1992
39. Oehm A, Behrmann I, Falk W, et al: Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J Biol Chem 267:10709-10715, 1992
40. Trauth BC, Klas C, Peters AM, et al: Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301-305, 1989
41. Ibanez CF, Ebendal T, Barbany G, et al: Disruption of the low affinity receptor- binding site in NGF allows neuronal survival and differentiation by binding to the trk gene product. Cell 69:329-341, 1992
42. Lee KF, Li E, Huber LJ, et al: Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system. Cell 69:737-749, 1992